Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Advanced Manufacturing (7)
- Biology and Environment (59)
- Biology and Soft Matter (1)
- Clean Energy (123)
- Climate and Environmental Systems (2)
- Computational Engineering (2)
- Computer Science (7)
- Electricity and Smart Grid (1)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (1)
- Fusion and Fission (34)
- Fusion Energy (13)
- Isotope Development and Production (1)
- Isotopes (27)
- Materials (114)
- Materials Characterization (1)
- Materials for Computing (20)
- Materials Under Extremes (1)
- Mathematics (1)
- National Security (30)
- Neutron Science (37)
- Nuclear Science and Technology (40)
- Nuclear Systems Modeling, Simulation and Validation (2)
- Sensors and Controls (1)
- Supercomputing (97)
- Transportation Systems (2)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.